Compare LGIH & ASPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LGIH | ASPI |
|---|---|---|
| Founded | 2003 | 2021 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Homebuilding | Major Chemicals |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.0B |
| IPO Year | 2013 | 2022 |
| Metric | LGIH | ASPI |
|---|---|---|
| Price | $54.09 | $5.95 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 5 | 2 |
| Target Price | ★ $75.90 | $12.00 |
| AVG Volume (30 Days) | 370.0K | ★ 6.0M |
| Earning Date | 04-28-2026 | 04-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.09 | N/A |
| Revenue | ★ $1,705,504,000.00 | $23,849,000.00 |
| Revenue This Year | $2.32 | $68.41 |
| Revenue Next Year | $17.94 | $126.69 |
| P/E Ratio | $591.89 | ★ N/A |
| Revenue Growth | N/A | ★ 475.48 |
| 52 Week Low | $33.55 | $3.92 |
| 52 Week High | $69.42 | $14.49 |
| Indicator | LGIH | ASPI |
|---|---|---|
| Relative Strength Index (RSI) | 67.13 | 46.17 |
| Support Level | $46.75 | $4.84 |
| Resistance Level | $55.13 | $6.19 |
| Average True Range (ATR) | 2.30 | 0.74 |
| MACD | 0.63 | -0.13 |
| Stochastic Oscillator | 89.84 | 28.13 |
LGI Homes Inc is engaged in the design, construction, and sale of new homes in markets. The company's current product offerings include entry-level homes, including both detached homes and townhomes, and move-up homes sold, which are sold under the LGI Homes brand, and luxury series homes, which are sold under the Terrata Homes brand. It offers a set number of floor plans in each community with features that include upgrades, such as granite countertops, appliances, and ceramic tile flooring. The company has seven operating segments: West, Northwest, Central, Midwest, Florida, Southeast, and Mid-Atlantic. The majority of the revenue is generated from the Central division segment.
ASP Isotopes Inc is a materials company focused on producing and commercializing enriched isotopes for the nuclear medicine, healthcare, green energy, and quantum computing industries. Using proprietary technology-the Aerodynamic Separation Process (ASP)-the company enriches isotopes in South Africa, targeting high-value, low-volume markets to reduce reliance on foreign supply chains. Geographically, the company operates in South Africa, Hong Kong and United States generating key revenue from the Hong Kong region.